(Q33401001)

English

Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS) (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

myelodysplastic syndrome

1 reference

based on heuristic

inferred from title

David P. Steensma

6

object named as

David P Steensma

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Guillermo Garcia-Manero

10

object named as

Guillermo Garcia-Manero

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Azra Raza

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Naomi Galili

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Deborah Mulford

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Scott E Smith

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Gail L Brown

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Roger M Lyons

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ralph Boccia

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Mikkael A Sekeres

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ruben A Mesa

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

30 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Journal of Hematology & Oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

30 April 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

21 June 2018

Oral Ezatiostat HCl (TLK199) and Myelodysplastic syndrome: a case report of sustained hematologic response following an abbreviated exposure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

21 June 2018

Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

21 June 2018

Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

21 June 2018

Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

21 June 2018

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

21 June 2018

Cytogenetics in acute leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

21 June 2018

The myelodysplastic syndrome(s): a perspective and review highlighting current controversies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

21 June 2018

Report of an international working group to standardize response criteria for myelodysplastic syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

21 June 2018

International scoring system for evaluating prognosis in myelodysplastic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

21 June 2018

A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q.

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-5-18

21 January 2018

A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416694

31 October 2018

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

1 reference

https://api.crossref.org/works/10.1186%2F1756-8722-5-18

21 January 2018

Identifiers

10.1186/1756-8722-5-18

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

1 reference

https://scigraph.springernature.com/pub.10.1186/1756-8722-5-18

9 September 2019

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33401001&oldid=2195324944"